These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20038365)

  • 1. [Severe adult atopic dermatitis: treatment with mycophenolate mofetil in 8 patients].
    Ballester I; Silvestre JF; Pérez-Crespo M; Lucas A
    Actas Dermosifiliogr; 2009 Dec; 100(10):883-7. PubMed ID: 20038365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycophenolate mofetil therapy for moderate to severe atopic dermatitis.
    Murray ML; Cohen JB
    Clin Exp Dermatol; 2007 Jan; 32(1):23-7. PubMed ID: 17059445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycophenolate mofetil therapy in adult patients with recalcitrant atopic dermatitis.
    Dias-Polak D; Bergman R; Avitan-Hersh E
    J Dermatolog Treat; 2019 Feb; 30(1):49-51. PubMed ID: 29683760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycophenolate mofetil for severe childhood atopic dermatitis: experience in 14 patients.
    Heller M; Shin HT; Orlow SJ; Schaffer JV
    Br J Dermatol; 2007 Jul; 157(1):127-32. PubMed ID: 17489974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First experience with enteric-coated mycophenolate sodium (Myfortic) in severe recalcitrant adult atopic dermatitis: an open label study.
    van Velsen SG; Haeck IM; Bruijnzeel-Koomen CA; de Bruin-Weller MS
    Br J Dermatol; 2009 Mar; 160(3):687-91. PubMed ID: 19120337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ten years experience with oral immunosuppressive treatment in adult patients with atopic dermatitis in two academic centres.
    Garritsen FM; Roekevisch E; van der Schaft J; Deinum J; Spuls PI; de Bruin-Weller MS
    J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1905-12. PubMed ID: 25752497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil is effective in the treatment of atopic dermatitis.
    Grundmann-Kollmann M; Podda M; Ochsendorf F; Boehncke WH; Kaufmann R; Zollner TM
    Arch Dermatol; 2001 Jul; 137(7):870-3. PubMed ID: 11453805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of atopic eczema with oral mycophenolate mofetil.
    Neuber K; Schwartz I; Itschert G; Dieck AT
    Br J Dermatol; 2000 Aug; 143(2):385-91. PubMed ID: 10951150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. The Mycophenolate Mofetil Renal Refractory Rejection Study Group.
    Transplantation; 1996 Mar; 61(5):722-9. PubMed ID: 8607174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate Mofetil in Severe Atopic Dermatitis: A Review.
    Prussick L; Plotnikova N; Gottlieb A
    J Drugs Dermatol; 2016 Jun; 15(6):715-8. PubMed ID: 27272078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect and safety of mycophenolate mofetil in chronic pulmonary sarcoidosis: a retrospective study.
    Brill AK; Ott SR; Geiser T
    Respiration; 2013; 86(5):376-83. PubMed ID: 23295253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial.
    Haeck IM; Knol MJ; Ten Berge O; van Velsen SG; de Bruin-Weller MS; Bruijnzeel-Koomen CA
    J Am Acad Dermatol; 2011 Jun; 64(6):1074-84. PubMed ID: 21458107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil in primary central nervous system vasculitis.
    Salvarani C; Brown RD; Christianson TJ; Huston J; Giannini C; Miller DV; Muratore F; Hunder GG
    Semin Arthritis Rheum; 2015 Aug; 45(1):55-9. PubMed ID: 25800827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolate mofetil versus azathioprine in the maintenance therapy of lupus nephritis.
    Sahin GM; Sahin S; Kiziltas S; Masatlioglu S; Oguz F; Ergin H
    Ren Fail; 2008; 30(9):865-9. PubMed ID: 18925525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review.
    Roekevisch E; Spuls PI; Kuester D; Limpens J; Schmitt J
    J Allergy Clin Immunol; 2014 Feb; 133(2):429-38. PubMed ID: 24269258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
    Transplantation; 1996 Apr; 61(7):1029-37. PubMed ID: 8623181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
    Kwinta-Rybicka J; Wilkosz K; Wierzchowska-Słowiacze EK; Ogarek I; Moczulska A; Stec Z; Pełkowska A; Sancewicz-Pach K; Pietrzyk JA
    Przegl Lek; 2006; 63 Suppl 3():44-8. PubMed ID: 16898486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil for the treatment of scleritis.
    Sen HN; Suhler EB; Al-Khatib SQ; Djalilian AR; Nussenblatt RB; Buggage RR
    Ophthalmology; 2003 Sep; 110(9):1750-5. PubMed ID: 13129873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficiency of mycophenolate mofetil in the treatment of intermediate and posterior uveitis].
    Greiner K; Varikkara M; Santiago C; Forrester JV
    Ophthalmologe; 2002 Sep; 99(9):691-4. PubMed ID: 12219257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescribing practices for systemic agents in the treatment of severe pediatric atopic dermatitis in the US and Canada: The PeDRA TREAT survey.
    Totri CR; Eichenfield LF; Logan K; Proudfoot L; Schmitt J; Lara-Corrales I; Sugarman J; Tom W; Siegfried E; Cordoro K; Paller AS; Flohr C
    J Am Acad Dermatol; 2017 Feb; 76(2):281-285. PubMed ID: 27855965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.